These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25084172)

  • 1. Introduction to a special issue on cytokines in neuroinflammation and immunity.
    Dhib-Jalbut S; Kalvakolanu DV
    J Interferon Cytokine Res; 2014 Aug; 34(8):557-8. PubMed ID: 25084172
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis.
    Zhang X; Hupperts R; De Baets M
    Immunol Res; 2003; 28(1):61-78. PubMed ID: 12947225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into adaptive immunity in chronic neuroinflammation.
    Siffrin V; Brandt AU; Herz J; Zipp F
    Adv Immunol; 2007; 96():1-40. PubMed ID: 17981203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The trimolecular complex as a target for specific immunotherapy in experimental autoimmune encephalomyelitis--applications for multiple sclerosis and other human autoimmune disease].
    Miller A; Weiner HL; Abramsky O
    Harefuah; 1992 Aug; 123(3-4):110-5. PubMed ID: 1516860
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune-based therapy of multiple sclerosis.
    Kaufman MD
    N C Med J; 1995 Aug; 56(8):379-84. PubMed ID: 7566191
    [No Abstract]   [Full Text] [Related]  

  • 6. Special issue on molecular basis of multiple sclerosis.
    Prat A
    Biochim Biophys Acta; 2011 Feb; 1812(2):131. PubMed ID: 21168062
    [No Abstract]   [Full Text] [Related]  

  • 7. EAE: imperfect but useful models of multiple sclerosis.
    't Hart BA; Gran B; Weissert R
    Trends Mol Med; 2011 Mar; 17(3):119-25. PubMed ID: 21251877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for Targeting Myeloid Cells in Controlling CNS Inflammation.
    Ifergan I; Miller SD
    Front Immunol; 2020; 11():571897. PubMed ID: 33123148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental autoimmune encephalomyelitis].
    Cornet A; Vizler C; Liblau R
    Rev Neurol (Paris); 1998 Sep; 154(8-9):586-91. PubMed ID: 9809373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T lymphocyte in experimental allergic encephalomyelitis.
    Zamvil SS; Steinman L
    Annu Rev Immunol; 1990; 8():579-621. PubMed ID: 2188675
    [No Abstract]   [Full Text] [Related]  

  • 11. Animal models for multiple sclerosis.
    Owens T
    Adv Neurol; 2006; 98():77-89. PubMed ID: 16400828
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological aspects of multiple sclerosis.
    Hughes RA
    Br J Hosp Med; 1977 Nov; 18(5):467-8, 470, 473-6. PubMed ID: 597658
    [No Abstract]   [Full Text] [Related]  

  • 13. Dendritic cells in brain diseases.
    Ludewig P; Gallizioli M; Urra X; Behr S; Brait VH; Gelderblom M; Magnus T; Planas AM
    Biochim Biophys Acta; 2016 Mar; 1862(3):352-67. PubMed ID: 26569432
    [No Abstract]   [Full Text] [Related]  

  • 14. From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis.
    Steinman L; Lindsey JW; Alters S; Hodgkinson S
    Immunol Ser; 1993; 59():253-60. PubMed ID: 8461390
    [No Abstract]   [Full Text] [Related]  

  • 15. EAE is not a useful model for demyelinating disease.
    Behan PO; Chaudhuri A
    Mult Scler Relat Disord; 2014 Sep; 3(5):565-74. PubMed ID: 26265268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenic mechanisms in experimental allergic encephalomyelitis.
    Kálmán B; Lublin FD
    Curr Opin Neurol Neurosurg; 1993 Apr; 6(2):182-8. PubMed ID: 7683223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
    Martin R; McFarland HF
    Crit Rev Clin Lab Sci; 1995; 32(2):121-82. PubMed ID: 7598789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.
    Luchtman DW; Ellwardt E; Larochelle C; Zipp F
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):403-13. PubMed ID: 25153998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune pathogenesis of experimental autoimmune encephalomyelitis: lessons learned for multiple sclerosis?
    Kuerten S; Lehmann PV
    J Interferon Cytokine Res; 2011 Dec; 31(12):907-16. PubMed ID: 21936633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemplating autoimmunity in the Aegean islands.
    Walker LS; Ziegler S; Becher B
    Nat Immunol; 2016 Mar; 17(3):218-20. PubMed ID: 26882250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.